review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Jonathan Cohen | |
Syed M Shah | |||
Hema R Dalal | |||
Matthew McLaughlin | |||
Narendra R Desai | |||
P2860 | cites work | Multivariate analysis of nuclear magnetic resonance data--characterization of critical drug substance quality of gentamicin sulfate | Q30998760 |
Structure-activity relationships among the aminoglycoside antibiotics: role of hydroxyl and amino groups | Q34661679 | ||
Particulate contamination in selected parenteral drugs | Q36663279 | ||
Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics | Q41963259 | ||
Particulate matter contamination of intravenous antibiotics aggravates loss of functional capillary density in postischemic striated muscle | Q43890600 | ||
Inline fluid dynamics in piggyback and manifold drug delivery systems | Q46458366 | ||
Microparticulate-induced phlebitis. Its prevention by in-line filtration | Q69880623 | ||
Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration | Q72361288 | ||
Compatibility of piperacillin sodium plus tazobactam with selected drugs during simulated Y-site injection | Q72516519 | ||
Linking extractables and leachables in container/closure applications | Q81337699 | ||
Zinc content of commercial diluents widely used in drug admixtures prepared for intravenous infusion | Q95411349 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P921 | main subject | piperacillin/tazobactam | Q7197337 |
P304 | page(s) | 303-314 | |
P577 | publication date | 2008-04-01 | |
P1433 | published in | Therapeutics and Clinical Risk Management | Q15766913 |
P1476 | title | Zosyn (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer's solutions and selected aminoglycosides | |
P478 | volume | 4 |
Q38284458 | Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014. |
Q42099155 | Do formulation differences between the reference listed drug and generic piperacillin-tazobactam impact reconstitution? |
Q39516974 | Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model |
Q43603048 | Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusions |
Q39212088 | Stability of aseptically prepared tazocin solutions in polyvinyl chloride bags |
Q84657307 | Structural characterization of the tobramycin-piperacillin reaction product formed at pH 6.0. |
Q43859114 | The interaction between piperacillin-tazobactam and Aspergillus galactomannan antigenemia assay: is the story over? |
Q53187811 | Visual and absorbance analyses of admixtures containing vancomycin and piperacillin-tazobactam at commonly used concentrations. |
Q42233062 | Y-site compatibility of vancomycin and piperacillin/tazobactam at commonly utilized pediatric concentrations |
Search more.